According to the American Cancer Society, more than half of all cancer deaths could be prevented by making healthy lifestyle choices, such as eating nutritiously and staying active. But, until now, no studies have shown if such changes can affect … Continue reading
Skin cancer is the most common type of cancer, accounting for nearly half of all cancers in the United States. Melanoma is a form of skin cancer that begins in the melanocytes, which are the cells that give skin its … Continue reading
VCU Massey Cancer Center has opened a Phase I clinical trial testing an innovative radiation therapy for patients with early stage prostate cancer that has the potential to drastically reduce treatment time. In comparison to the standard schedule of eight … Continue reading
A novel therapy in the early stages of development at Virginia Commonwealth University Massey Cancer Center shows promise in providing lasting protection against the progression of multiple myeloma following a stem cell transplant by making the cancer cells easier targets … Continue reading
Maria Quigley, R.N., and Andrew Poklepovic, M.D., are conducting clinical trial studying a combination of chemotherapies for the treatment of advanced malignancies. Since 1974, VCU Massey Cancer Center has been at the forefront of groundbreaking research to help save and improve … Continue reading
Patients who use an interactive personal health record (IPHR) are almost twice as likely to be up to date with clinical preventive services as those who do not, according to a new study led by Alex Krist, M.D., M.P.H., research … Continue reading
Researchers at Virginia Commonwealth University (VCU) Massey Cancer Center‘s Bone Marrow Transplant Program have demonstrated that the use of antibodies derived from rabbits can improve the survival and relapse outcomes of leukemia and myelodysplasia patients receiving a stem cell transplant … Continue reading
VCU Massey Cancer Center continues to test new technology by ApoCell, Inc. that can detect circulating tumor cells (CTC) in a patient’s bloodstream. In April, Massey reported on a pilot study of the device in liver cancer patients, and now … Continue reading
A recent Phase I/II clinical trial has shown that a new combination of radiation therapies developed at Virginia Commonwealth University Massey Cancer Center escalates radiation doses to safely and effectively treat prostate cancer and lower the risk of recurrence with … Continue reading
Egidio Del Fabbro, M.D., has been named program director of palliative care at Virginia Commonwealth University Massey Cancer Center, effective May 1, 2012. A nationally recognized expert in palliative care – comprehensive care for patients and families with a focus … Continue reading